Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 17/20 | 0.78 |
| ▸ | MTNR1B | P49286 | 17/20 | 0.78 |
| ▸ | NQO2 | P16083 | 3/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.76 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31530480 | 1.00 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL31530479 | 1.00 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL8946916 | 0.88 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL31543713 | 0.88 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| Iodomelatonin SCHEMBL29759473 | 0.86 | MTNR1A (0.76) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| Iodomelatonin SCHEMBL163451 | 0.86 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL1774151 | 0.86 | NQO2 (1.00) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL1311849 | 0.86 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL3221458 | 0.86 | KDM4E (0.84) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 | |
| SCHEMBL8686010 | 0.85 | MTNR1A (0.77) | MTNR1AMTNR1BNQO2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255923-A1 | METHODS FOR EXTRACTING MELATONIN AND COMPOSITIONS THEREOF | NUTRALAND USA INC (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025096325-A1 | METHODS FOR EXTRACTING MELATONIN | NUTRALAND USA, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| US-20250135377-A1 | METHODS FOR EXTRACTING MELATONIN | NUTRALAND USA, INC. | 2025-05-01 | — | — | US | claimed |
| US-20070218023-A1 | Uses of melatonin in skin | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2007-09-20 | — | — | US | claimed |
| US-20250255923-A1 | METHODS FOR EXTRACTING MELATONIN AND COMPOSITIONS THEREOF | NUTRALAND USA INC (US) | 2025-08-14 | — | — | US | disclosed |
| WO-2025096325-A1 | METHODS FOR EXTRACTING MELATONIN | NUTRALAND USA, INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-20250135377-A1 | METHODS FOR EXTRACTING MELATONIN | NUTRALAND USA, INC. | 2025-05-01 | — | — | US | disclosed |
| US-20250064701-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIVERSIDAD DE GRANADA (ES) | 2025-02-27 | — | — | US | disclosed |
| US-20230414470-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIVERSIDAD DE GRANADA (ES) | 2023-12-28 | — | — | US | disclosed |
| US-20230031519-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIVERSIDAD DE GRANADA (ES) | 2023-02-02 | — | — | US | disclosed |
| EP-2926800-B1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIV GRANADA (ES) | 2019-05-29 | — | — | EP | disclosed |
| US-20180311133-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIVERSIDAD DE GRANADA (ES) | 2018-11-01 | — | — | US | disclosed |
| US-10092544-B2 | Composition comprising melatonin or its derivatives with coenzyme Q10 and use thereof against ageing of the skin | UNIVERSIDAD DE GRANADA (ES) | 2018-10-09 | — | — | US | disclosed |
| US-20150306072-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | UNIVERSIDAD DE GRANADA (ES) | 2015-10-29 | — | — | US | disclosed |
| EP-2926800-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | Universidad de Granada (ES) | 2015-10-07 | — | — | EP | disclosed |
| US-20070218023-A1 | Uses of melatonin in skin | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2007-09-20 | — | — | US | disclosed |
| US-20070218023-A1 | Uses of melatonin in skin | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230414470-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
| US-20250064701-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
| US-10092544-B2 | Composition comprising melatonin or its derivatives with coenzyme Q10 and use thereof against ageing of the skin | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
| US-20150306072-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
| US-20180311133-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
| US-20230031519-A1 | COMPOSITION COMPRISING MELATONIN OR ITS DERIVATIVES WITH COENZYME Q10 AND USE THEREOF AGAINST AGEING OF THE SKIN | NDUFA10, NDUFB10, TIMM10 | MTNR1A 60/4885MTNR1B 90/4885NQO2 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.